High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections

2006848 citationsJournal Article

Authors

Abstract

High prevalence of clinical MRSA strains with elevated vancomycin MIC (2 microg/mL) requires aggressive empirical vancomycin dosing to achieve a trough greater than 15 microg/mL. Combination or alternative therapy should be considered for invasive infections caused by these strains.

Topics & Keywords

Antimicrobial Resistance in Staphylococcus Bacterial Identification and Susceptibility Testing Antibiotics Pharmacokinetics and Efficacy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of Internal Medicine

Volume 166, Issue 19, pp. 2138-2138

DOI: 10.1001/archinte.166.19.2138

Field-Weighted Citation Impact: 28.12